110 related articles for article (PubMed ID: 19294626)
21. Circ_0010235 facilitates lung cancer development and immune escape by regulating miR-636/PDL1 axis.
Zhao J; Yan W; Huang W; Li Y
Thorac Cancer; 2022 Apr; 13(7):965-976. PubMed ID: 35167195
[TBL] [Abstract][Full Text] [Related]
22. Novel Cellular Therapies for Hepatocellular Carcinoma.
Roddy H; Meyer T; Roddie C
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158772
[TBL] [Abstract][Full Text] [Related]
23. Clinical Studies on Cytokine-Induced Killer Cells: Lessons from Lymphoma Trials.
Zhang Y; Sharma A; Weiher H; Schmid M; Kristiansen G; Schmidt-Wolf IGH
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885117
[TBL] [Abstract][Full Text] [Related]
24. Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect.
Nava S; Lisini D; Frigerio S; Bersano A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830221
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Enhanced Cytokine-Induced Killer Cells as an Adjuvant Immunotherapy for Renal Cell Carcinoma: Preclinical and Clinical Studies.
Yang Y; Wang RQ; Zhong YM; Meng MY; Zhao YY; Yang LR; Li L; Hou ZL
J Healthc Eng; 2021; 2021():5709104. PubMed ID: 34540187
[TBL] [Abstract][Full Text] [Related]
26. Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective.
Donini C; Rotolo R; Proment A; Aglietta M; Sangiolo D; Leuci V
Cells; 2021 Mar; 10(3):. PubMed ID: 33806296
[TBL] [Abstract][Full Text] [Related]
27. Immune checkpoint inhibitors and cellular treatment for lymphoma immunotherapy.
Li F; Chen Y; Pang M; Yang P; Jing H
Clin Exp Immunol; 2021 Jul; 205(1):1-11. PubMed ID: 33675535
[TBL] [Abstract][Full Text] [Related]
28. Superior Antitumor Efficacy of IFN-α2b-Incorporated Photo-Cross-Linked Hydrogels Combined with T Cell Transfer and Low-Dose Irradiation Against Gastric Cancer.
Liu Q; Zhang D; Qian H; Chu Y; Yang Y; Shao J; Xu Q; Liu B
Int J Nanomedicine; 2020; 15():3669-3680. PubMed ID: 32547021
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-35 as an Emerging Player in Tumor Microenvironment.
Xue W; Yan D; Kan Q
J Cancer; 2019; 10(9):2074-2082. PubMed ID: 31205568
[TBL] [Abstract][Full Text] [Related]
30. Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.
Mesiano G; Grignani G; Fiorino E; Leuci V; Rotolo R; D'Ambrosio L; Salfi C; Gammaitoni L; Giraudo L; Pisacane A; Butera S; Pignochino Y; Basiricó M; Capozzi F; Sapino A; Aglietta M; Sangiolo D
Oncoimmunology; 2018; 7(11):e1465161. PubMed ID: 30393581
[TBL] [Abstract][Full Text] [Related]
31. Programmed Death Receptor 1 (PD1) Knockout and Human Telomerase Reverse Transcriptase (hTERT) Transduction Can Enhance Persistence and Antitumor Efficacy of Cytokine-Induced Killer Cells Against Hepatocellular Carcinoma.
Huang K; Sun B; Luo N; Guo H; Hu J; Peng J
Med Sci Monit; 2018 Jul; 24():4573-4582. PubMed ID: 29967316
[TBL] [Abstract][Full Text] [Related]
32. Influence of different ex vivo cell culture methods on the proliferation and anti-tumor activity of cytokine-induced killer cells from gastric cancer patients.
Shi B; Sun A; Zhang X
Onco Targets Ther; 2018; 11():2657-2672. PubMed ID: 29780258
[TBL] [Abstract][Full Text] [Related]
33. CD44v6 as innovative sarcoma target for CAR-redirected CIK cells.
Leuci V; Casucci GM; Grignani G; Rotolo R; Rossotti U; Vigna E; Gammaitoni L; Mesiano G; Fiorino E; Donini C; Pisacane A; Ambrosio LD; Pignochino Y; Aglietta M; Bondanza A; Sangiolo D
Oncoimmunology; 2018; 7(5):e1423167. PubMed ID: 29721373
[TBL] [Abstract][Full Text] [Related]
34. Innovative Clinical Perspectives for CIK Cells in Cancer Patients.
Introna M; Correnti F
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29370095
[TBL] [Abstract][Full Text] [Related]
35. All-trans retinoic acid enhances cytotoxicity of CIK cells against human lung adenocarcinoma by upregulating MICA and IL-2 secretion.
Fan XY; Wang PY; Zhang C; Zhang YL; Fu Y; Zhang C; Li QX; Zhou JN; Shan BE; He DW
Sci Rep; 2017 Nov; 7(1):16481. PubMed ID: 29184163
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials.
Wang Y; Lv B; Li K; Zhang A; Liu H
Drug Des Devel Ther; 2017; 11():3245-3256. PubMed ID: 29180849
[TBL] [Abstract][Full Text] [Related]
37. Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature review.
Zhang Y; Qi Y; Wang A; Ma B; Fu X; Zhao L; Gao Q
Onco Targets Ther; 2017; 10():4687-4690. PubMed ID: 29026316
[TBL] [Abstract][Full Text] [Related]
38. Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus.
Zhao X; Ouyang W; Chester C; Long S; Wang N; He Z
PLoS One; 2017; 12(9):e0184816. PubMed ID: 28922411
[TBL] [Abstract][Full Text] [Related]
39. Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.
Mesiano G; Zini R; Montagner G; Bianchi N; Manfredini R; Chillemi A; Aglietta M; Grignani G; Lampronti I; Fiorino E; Malavasi F; Sangiolo D; Gambari R; Ferrari D
Mol Med; 2017 Oct; 23():235-246. PubMed ID: 28805233
[TBL] [Abstract][Full Text] [Related]
40. FOLFOX regimen plus dendritic cells-cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis.
Liu Y; Zheng Z; Zhang Q; Zhou X; Feng Y; Yan A
Onco Targets Ther; 2017; 10():2621-2633. PubMed ID: 28572734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
